Back To: Home

CLICK HERE FOR WHAT'S NEW IN:
 




 

Thrive announces instruments and services agreement with Harvard Stem Cell Institute
September 2016
SHARING OPTIONS:

WAKEFIELD, Mass.—Recently, Thrive Bioscience, a manufacturer of automated cell culture management systems, and the Harvard Stem Cell Institute (HSCI) in Cambridge, Mass., announced an agreement under which Thrive will develop instruments for the growth and maintenance of induced pluripotent stem cells (iPSCs). The agreement includes development of automated iPSC protocols critical to HSCI and its researchers. HSCI plans to utilize the Thrive systems within the Harvard Stem Cell Institute iPS Core Facility and affiliated research sites.
 
Terms of the agreement include HSCI gaining early access to the Thrive Bioscience technology, purchase of multiple Thrive Bioscience systems by HSCI, protocol development in advanced stem cell applications (including colony sub-cloning in preparation for gene editing) and the production of iPSC-derived normal and disease-state cell lines. These applications are said to be integral to new, groundbreaking approaches in the discovery of patient therapies and regenerative medicine.
 
“This agreement provides Thrive Bioscience the opportunity to develop systems for world-renowned researchers at Harvard Stem Cell Institute in the highly dynamic and expanding field of stem cell technology,” said the company’s chief scientific officer and co-founder, Dr. Alan-Philippe Blanchard. “The result is the development of a comprehensive product that meets industry and researcher needs.”

Back



PAGE UTILITIES


CONTACT US
DDNEWS
Published by Old River Publications LLC
19035 Old Detroit Road
Rocky River, OH USA 44116
Ph: 440-331-6600  |  Fax: 440-331-7563
 
© Copyright 2017 Old River Publications LLC. All righs reserved.  |  Web site managed and designed by OffWhite.